Biodegradable microcapsules deliver nerve growth factor to guide neuronal development

February 16, 2021

Researchers from Skoltech and their colleagues have demonstrated that nanoengineered biodegradable microcapsules can guide the development of hippocampal neurons in an in vitro experiment. The microcapsules deliver nerve growth factor, a peptide necessary for neuron growth. The paper describing this work was published in the journal Pharmaceutics.

Many neurodegenerative conditions that can lead to severe disorders are associated with depleted levels of growth factors in the brain - neuropeptides that help neurons grow, proliferate and survive. Some clinical studies of Alzheimer's and Parkinson's diseases have shown that delivering these growth factors to specific degenerating neurons can have a therapeutic effect. However, it is rather hard to do in practice; when taken systemically, as a typical drug, they can have difficulty penetrating the blood-brain barrier and severe side effects. And using viruses to deliver them as a form of gene therapy means one cannot easily stop the treatment once it is initiated, which also leads to safety concerns.

Olga Sindeeva and Gleb Sukhorukov of Skoltech and Queen Mary University of London, together with their colleagues, decided to try to use targeted delivery in the form of microcapsules with an average size of 2 to 3 micrometers bringing one of these neuropeptides, nerve growth factor (NGF), directly to the needed location. To produce the capsules, the team used poly-L-arginine and dextran and the layer-by-layer technique, when very thin films are deposited, as the name suggests, layer by layer to form a capsule. Earlier studies showed that these capsules are biocompatible and can function properly both in tissue slices and in rodents, with no detectable adverse effects.

"Encapsulation via Layer-by-Layer (LbL) technology has an advantage, first of all, in its versatility, meaning the possibility to tailor different functions to the shell of the capsules and incorporate various cargo. Also, unlike many other encapsulation methods, LbL encapsulation is processed in aqueous conditions, which is absolutely compatible with such fragile molecules as some peptides, proteins and in particular growth factors," Sukhorukov said.

For their new experiment, researchers used cultures of rat hippocampal neurons, which were studied after adding the microcapsules. It turned out that NGF that was delivered in them boosted neuronal growth quite significantly, and this new growth was not arbitrary but rather directed towards the clusters of microcapsules. NGF also enhanced neurite branching, a process that leads to the formation of axons and dendrites, the main functional elements of a neuron. Finally, neurons treated with NGF in microcapsules were able to form functional synapses. If this approach works in clinical applications, it may mean a reversal of neurodegeneration observed in many diseases.

"The properties of LbL microcapsules can be tuned according to the application. So, biocompatibility, degradation and controlled release are defined by the choice of polymers used in capsule shell composition. Controlled release could also be achieved by external stimuli such as ultrasound, laser, or a magnetic field," Gleb Sukhorukov noted.

The team plans to test their technology of controlled release of NGF for a speedy recovery after neural injury. Earlier studies also showed that a similar approach can work with other growth factors such as basic fibroblast growth factor, a protein involved in a host of biological processes including embryonic development and tissue repair.
Other organizations involved in this research include University College London and Saratov State University.

Skoltech is a private international university located in Russia. Established in 2011 in collaboration with the Massachusetts Institute of Technology (MIT), Skoltech is cultivating a new generation of leaders in the fields of science, technology and business, is conducting research in breakthrough fields, and is promoting technological innovation with the goal of solving critical problems that face Russia and the world. Skoltech is focusing on six priority areas: data science and artificial intelligence, life sciences, advanced materials and modern design methods, energy efficiency, photonics and quantum technologies, and advanced research.


Skolkovo Institute of Science and Technology (Skoltech)

Related Microcapsules Articles from Brightsurf:

Magnetic field and hydrogels could be used to grow new cartilage
Instead of using synthetic materials, Penn Medicine study shows magnets could be used to arrange cells to grow new tissues

Scientists develop new precise therapeutic leukemia vaccine
Researchers from the Institute of Process Engineering (IPE) of the Chinese Academy of Sciences and Zhujiang Hospital of Southern Medical University have developed a new type of precise therapeutic vaccine against leukemia.

Scientists supercharge shellfish to tackle vitamin deficiency in humans
Cambridge scientists have developed a new way to fortify shellfish to tackle human nutrient deficiencies which cause severe health problems across the world.

Developing better fabrication techniques for pH-responsive microcapsules
Researchers have developed a new method to create microcapsules, which are tiny droplets surrounded by a solid shell.

Promising new method for producing tiny liquid capsules
Microcapsules for the storage and delivery of substances are tiny versions of the type of capsule used for fish oil or other liquid supplements.

Researchers develop high-performance cancer vaccine using novel microcapsules
Scientists from the Institute of Process Engineering (IPE) of the Chinese Academy of Sciences have developed a new therapeutic tumor vaccine based on self-healing polylactic acid microcapsules, which can efficiently activate the immune system and inhibit tumor development.

Novel tin 'bubbles' spur advances in the development of integrated chips
The use of extreme ultraviolet light sources in making advanced integrated chips has been considered, but their development has been hindered owing to a paucity of efficient laser targets.

Catalytic protocells get zingy
Artificial cells capable of oxygen gas production and chemical signalling have been prepared using a combination of synthetic and biological catalysts through an international collaboration between the University of Bristol and the University of Padua in Italy.

Microcapsules for targeted drug delivery to cancer cells
A team of scientists from Peter the Great St. Petersburg Polytechnic University together with their colleagues developed a method of targeted drug delivery to cancer cells.

Thinner shells for delivering gentler therapeutic bursts
Releasing drugs that are packaged into microcapsules requires a significant amount of force, and the resulting burst can cause damage to human tissues or cause blood clots.

Read More: Microcapsules News and Microcapsules Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to